Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 9NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Breast 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 54Specimen Handling 48aldesleukin 35Docetaxel 30Biopsy 28Bevacizumab 24Gemcitabine 21Cyclophosphamide 21Cisplatin 21Radiotherapy 19Prednisone 17Sorafenib 16Carboplatin 16sargramostim 15PROSTVAC 15Paclitaxel 14Interferon-alpha 14Sunitinib 13ixabepilone 12cabozantinib 12Immunoglobulin G 12Goserelin 12Disulfides 12fludarabine phosphate 11fludarabine 11Nivolumab 11Fluorouracil 11Chemotherapy, Adjuvant 11pembrolizumab 10bicalutamide 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Genistein × Genitourinary × Clear all
NCT00118040 2021-06-10

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled 24 charts
Genitourinary

Urinary Bladder Neoplasms

NCT01325311 2016-08-03

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
15 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

NCT00001696 2008-03-04

A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡